Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jeffrey L Silber"'
Autor:
Thomas Louie, Yoav Golan, Sahil Khanna, Dmitri Bobilev, Nathalie Erpelding, Candida Fratazzi, Meg Carini, Rajita Menon, Mary Ruisi, Jason M. Norman, Jeremiah J. Faith, Bernat Olle, Minran Li, Jeffrey L. Silber, Darrell S. Pardi
Publikováno v:
JAMA. 329:1356
ImportanceThe effect of rationally defined nonpathogenic, nontoxigenic, commensal strains of Clostridia on prevention of Clostridioides difficile infection (CDI) is unknown.ObjectiveTo determine the efficacy of VE303, a defined bacterial consortium o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c92c5ee724eaaa6798db8f4c438ac7f
https://doi.org/10.1001/jama.2023.4314
https://doi.org/10.1001/jama.2023.4314
Autor:
Melissa Dsouza, Rajita Menon, Emily Crossette, Shakti K. Bhattarai, Jessica Schneider, Yun-Gi Kim, Shilpa Reddy, Silvia Caballero, Cintia Felix, Louis Cornacchione, Jared Hendrickson, Andrea R. Watson, Samuel S. Minot, Nick Greenfield, Lisa Schopf, Rose Szabady, Juan Patarroyo, William Smith, Pratibha Harrison, Ed J. Kuijper, Ciaran P. Kelly, Bernat Olle, Dmitri Bobilev, Jeffrey L. Silber, Vanni Bucci, Bruce Roberts, Jeremiah Faith, Jason M. Norman
Publikováno v:
Cell Host & Microbe, 30(4), 583-598.e8. CELL PRESS
Manipulation of the gut microbiota via fecal microbiota transplantation (FMT) has shown clinical promise in diseases such as recurrent Clostridioides difficile infection (rCDI). However, the variable nature of this approach makes it challenging to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64d09823d48b803c9f7a60dbf0b671fc
https://hdl.handle.net/1887/3505720
https://hdl.handle.net/1887/3505720
Autor:
Thomas J. Louie, Yoav Golan, Sahil Khanna, Frederick W. Ruthardt, Candida Fratazzi, Meg Carini, Mary Ruisi, Nathalie Erpelding, Minran Li, Dmitri Bobilev, Jeffrey L. Silber, Darrell S. Pardi
Publikováno v:
Gastroenterology. 162:S-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4482c0636a966fcf9a79b08e9df495d6
https://doi.org/10.1016/s0016-5085(22)60052-0
https://doi.org/10.1016/s0016-5085(22)60052-0
Autor:
Rajita Menon, Emily M. Crossette, Shakti Bhattarai, Vanni Bucci, Jeremiah Faith, Mary Ruisi, Bernat Olle, Jeffrey L. Silber, Jason Norman
Publikováno v:
Gastroenterology. 162:S-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::719fd174594058ab8c57e99ed80bcd5b
https://doi.org/10.1016/s0016-5085(22)60519-5
https://doi.org/10.1016/s0016-5085(22)60519-5
Autor:
Emily M. Crossette, Rajita Menon, Esi S. Lamousé-Smith, Tokuwa Kanno, Ling-Yang Hao, Amanda Prince, Jeremiah Faith, Mary Ruisi, Bernat Olle, Jeffrey L. Silber, Jason Norman
Publikováno v:
Gastroenterology. 162:S-107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76a3c416858e00d3f4ac20e19e2ac0cf
https://doi.org/10.1016/s0016-5085(22)60267-1
https://doi.org/10.1016/s0016-5085(22)60267-1
Autor:
Katia Schlienger, Jin Xu, Chester L. Fisher, Wolfgang Spieler, Janie Parrino, Jon E. Stek, Xiaoming Li, Shu-Chih Su, Kathleen E. Coll, Jeffrey L. Silber, Amy Falk Russell
Publikováno v:
Vaccine. 33:3129-3134
Background This randomized, placebo-controlled study assessed the safety, tolerability, and immunogenicity of live virus zoster vaccine (ZV) in individuals receiving chronic/maintenance systemic corticosteroid therapy (daily dose equivalent of 5–20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df11f9fc27410730ba940434f172c0f
https://doi.org/10.1016/j.vaccine.2015.04.090
https://doi.org/10.1016/j.vaccine.2015.04.090
Autor:
Vicki A, Morrison, Michael N, Oxman, Myron J, Levin, Kenneth E, Schmader, John C, Guatelli, Robert F, Betts, Larry D, Gelb, Constance T, Pachucki, Susan K, Keay, Barbara, Menzies, Marie R, Griffin, Carol A, Kauffman, Adriana R, Marques, John F, Toney, Michael S, Simberkoff, Richard, Serrao, Robert D, Arbeit, John W, Gnann, Richard N, Greenberg, Mark, Holodniy, Wendy A, Keitel, Shingshing S, Yeh, Larry E, Davis, George E, Crawford, Kathy M, Neuzil, Gary R, Johnson, Jane H, Zhang, Rith, Harbecke, Ivan S F, Chan, Paul M, Keller, Heather M, Williams, Kathy D, Boardman, Jeffrey L, Silber, Paula W, Annunziato, J F, Toney
Publikováno v:
The Journal of Infectious Diseases. 208:559-563
Background. After completion of the Shingles Prevention Study (SPS; Department of Veterans Affairs Cooperative Studies Program Number 403), SPS participants who had initially received placebo were offered investigational zoster vaccine without charge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e40304f8a8b1a4814f972bf828f6742
https://doi.org/10.1093/infdis/jit182
https://doi.org/10.1093/infdis/jit182
Autor:
Jeffrey L. Silber, Myron J. Levin, Gary O. Zerbe, Kenny H. Chan, Anthony R. Hayward, Rob Roy MacGregor, Anne A. Gershon, Ivan S. F. Chan, Adriana Weinberg, Rupert Vessey, Ann A. Lazar
Publikováno v:
The Journal of Infectious Diseases. 201:1024-1030
Varicella-zoster virus (VZV)–specific cell-mediated immunity responses are essential for recovery from primary (varicella) or reactivation (herpes zoster) infection with VZV [1-4]. Patients who lack adequate VZV-specific cell-mediated immunity ofte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6341a4f94ebee019345365b51024e55
https://doi.org/10.1086/651199
https://doi.org/10.1086/651199
Autor:
Rocio D. Marchese, Carla Painter, Michael D. Blum, Frances B. Alvarez, Bonnie Bushnell, Richard D. McFetridge, Jeffrey L. Silber, Susan B. Manoff, Charlie Liss, Daniel M. Musher
Publikováno v:
The Journal of Infectious Diseases. 201:516-524
Background This study assessed antibody levels for 5 years after primary vaccination or revaccination with 23-valent pneumococcal polysaccharide vaccine (PN23). Methods Subjects were enrolled into 4 study groups by age (50-64 or > or = 65 years) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f58fc4c9202e19ace7dc45f80b89880a
https://doi.org/10.1086/649839
https://doi.org/10.1086/649839
Autor:
Rocio D. Marchese, Michael J. Caulfield, Jeffrey L. Silber, George M. Carlone, Susan B. Manoff, Gowrisankar Rajam, Sandra Romero-Steiner, Cynthia G. Whitney, Charles Liss, Nina E. Glass, John Boslego
Publikováno v:
The Journal of Infectious Diseases. 201:525-533
BACKGROUND: Older adults are at high risk of developing invasive pneumococcal disease, but the optimal timing and number of vaccine doses needed to prevent disease among this group are unknown. We compared revaccination with 23-valent pneumococcal po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9de51f7bb887c79c3b13f62bdbd4c5
https://doi.org/10.1086/651131
https://doi.org/10.1086/651131